Debio 1347-101 Phase I Trial in Advanced Solid Tumours With Fibroblast Growth Factor Receptor (FGFR) Alterations
A Phase I, Gene Alteration-based, Open Label, Multicenter Study of Oral Debio 1347 (CH5183284) in Patients With Advanced Solid Malignancies, Whose Tumours Have an Alteration of the FGFR 1, 2 or 3 Genes
Sponsor: Debiopharm International SA
Terminated
This trial was terminated. No reason was provided.
Other terminated trials from Debiopharm International SA
- Advanced Solid Tumors · Phase PHASE1 · Oct 2025
- Bone or Joint Infection · Phase PHASE2 · Apr 2025
- Advanced Solid Tumor · Phase PHASE1 · Feb 2025
- Acromegaly · Phase PHASE1 · Dec 2024
- Adult Solid Tumor · Phase PHASE1 · Aug 2024
More terminations from Debiopharm International SA
Other Solid Tumours trials with similar outcome
A PHASE1 clinical study on Solid Tumours, this trial is terminated or withdrawn. The trial is conducted by Debiopharm International SA and has accumulated 37 data snapshots since 2013. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
37 versions recorded-
Sep 2025 — Present [monthly]
Terminated PHASE1
-
Sep 2024 — Sep 2025 [monthly]
Terminated PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE1
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE1
-
Oct 2020 — Jan 2021 [monthly]
Terminated PHASE1
Status: Active Not Recruiting → Terminated
▶ Show 32 earlier versions
-
Sep 2020 — Oct 2020 [monthly]
Active Not Recruiting PHASE1
-
Aug 2020 — Sep 2020 [monthly]
Active Not Recruiting PHASE1
-
Jul 2020 — Aug 2020 [monthly]
Active Not Recruiting PHASE1
-
Jun 2020 — Jul 2020 [monthly]
Active Not Recruiting PHASE1
-
May 2020 — Jun 2020 [monthly]
Active Not Recruiting PHASE1
-
Apr 2020 — May 2020 [monthly]
Active Not Recruiting PHASE1
Status: Recruiting → Active Not Recruiting
-
Mar 2020 — Apr 2020 [monthly]
Recruiting PHASE1
-
Feb 2020 — Mar 2020 [monthly]
Recruiting PHASE1
-
Dec 2019 — Feb 2020 [monthly]
Recruiting PHASE1
-
Nov 2019 — Dec 2019 [monthly]
Recruiting PHASE1
-
Oct 2019 — Nov 2019 [monthly]
Recruiting PHASE1
-
Aug 2019 — Oct 2019 [monthly]
Recruiting PHASE1
-
Jul 2019 — Aug 2019 [monthly]
Recruiting PHASE1
-
Jun 2019 — Jul 2019 [monthly]
Recruiting PHASE1
-
May 2019 — Jun 2019 [monthly]
Recruiting PHASE1
-
Apr 2019 — May 2019 [monthly]
Recruiting PHASE1
-
Mar 2019 — Apr 2019 [monthly]
Recruiting PHASE1
-
Feb 2019 — Mar 2019 [monthly]
Recruiting PHASE1
-
Jan 2019 — Feb 2019 [monthly]
Recruiting PHASE1
-
Dec 2018 — Jan 2019 [monthly]
Recruiting PHASE1
-
Nov 2018 — Dec 2018 [monthly]
Recruiting PHASE1
-
Oct 2018 — Nov 2018 [monthly]
Recruiting PHASE1
-
Sep 2018 — Oct 2018 [monthly]
Recruiting PHASE1
-
Aug 2018 — Sep 2018 [monthly]
Recruiting PHASE1
-
Jul 2018 — Aug 2018 [monthly]
Recruiting PHASE1
-
Jun 2018 — Jul 2018 [monthly]
Recruiting PHASE1
-
Sep 2017 — Jun 2018 [monthly]
Recruiting PHASE1
Status: Active Not Recruiting → Recruiting
-
Aug 2017 — Sep 2017 [monthly]
Active Not Recruiting PHASE1
-
Jul 2017 — Aug 2017 [monthly]
Active Not Recruiting PHASE1
Status: Recruiting → Active Not Recruiting
-
May 2017 — Jul 2017 [monthly]
Recruiting PHASE1
-
Feb 2017 — May 2017 [monthly]
Recruiting PHASE1
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE1
First recorded
Aug 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Debiopharm International SA
For direct contact, visit the study record on ClinicalTrials.gov .